#MFN2
New in #OAC Zhang et al. demonstrated that Sestrin2 (SESN2) promotes chondrocyte mitochondrial dysfunction by regulating MFN2 dephosphorylation to induce mitochondrial hyperfusion, thereby providing a new potential target for intervention in OA.

www.sciencedirect.com/science/arti...
SESN2 drives osteoarthritis progression by inducing MFN2-dependent mitochondrial hyperfusion in rats
This study aimed to elucidate the role of SESN2 in the pathological process of osteoarthritis (OA), with a particular focus on its potential mechanism…
www.sciencedirect.com
October 30, 2026 at 2:32 PM
❗❗❗Honored to be cited in Science Advances
👏👏👏Prof. Lei Cao’ team discovers that an imbalance in mitochondrial homeostasis, mediated by MFN2 in astrocytes, drives depression-like behaviors.
BrainVTA offers AAV packaging services.
www.science.org/doi/10.1126/...
MFN2-associated astrocyte dysfunction contributes to neuronal hyperexcitability and depressive-like behaviors
Astrocyte pathology is increasingly recognized as a key factor in the pathogenesis of major depressive disorder (MDD), where disrupted glutamate clearance and impaired neuron-glia interactions contrib...
www.science.org
October 21, 2026 at 8:21 AM
@thermofishersci.bsky.social's resource, RRID:AB_2534782, was just reported to be used in the paper. Thanks for making your methods matter! #methodsmatter #RRID #BetterScience
Mitofusin-2 (MFN2) is a critical regulator of metabolic homeostasis in neuronal cells: A metabolomic and proteomic study
Read the full paper: Mitofusin-2 (MFN2) is a critical regulator of metabolic homeostasis in neuronal cells: A metabolomic and proteomic study
doi.org
October 18, 2026 at 7:00 AM
To test this notion, Mashiat re-expressed a series of pathogenic MFN2 variants in MFN2 KO cells. The MFN2 variants represented a variety of pathogenic phenotypes, and allowed us to identify conserved cellular functions that correlated with specific pathologies.
September 30, 2026 at 12:58 PM
While pathogenic variant in MFN2 are well known to cause peripheral neuropathy, some variants can cause other pathologies, either in addition to or separate from peripheral neuropathy.

How MFN2 dysfunction leads to these different pathologies was a key question driving Mashiat's PhD project.
September 30, 2026 at 12:58 PM
This led us to wonder if distinct types of MFN2 dysfunction might be linked to specific patient pathologies...
September 30, 2026 at 12:58 PM
Mugen 2v2: Natsu and Erza vs Toriel and Undyne
YouTube video by HarveyEdd
www.youtube.com
September 30, 2026 at 1:06 PM
We also were able to dig a bit deeper into the mechanism of mtDNA release. To our surprise, we found that MFN2 dysfunction can drive mtDNA release via two distinct pathways.
September 30, 2026 at 12:58 PM
While the endosome release pathway clearly correlates with myopathy, we still don't now the relevance of the MDV release pathway to MFN2 disease - though it does lead to a 2-3 fold increase in cGAS-STING inflammation.
September 30, 2026 at 12:58 PM
In the first paper (doi.org/10.64898/202...), we show that MFN2 variants causing ataxia have a unique lipid phenotype due to a gain of function that increases the transfer of fatty acids from lipid droplets to mitochondria.
doi.org
September 30, 2026 at 12:58 PM
In the second paper (doi.org/10.64898/202...), we show that MFN2 variants that cause myopathy promote mtDNA release via endosomes, which leads to increased inflammation via TLR9 and cGAS-STING pathways. We believe this inflammation is what drives the myopathy in the patients.
doi.org
September 30, 2026 at 12:58 PM
At the end of the day, we believe that Mashiat has uncovered two novel mechanisms by which MFN2 dysfunction leads to myopathy and ataxia.

Surprisingly, both pathways appear to be distinct from mitochondrial fusion, and both pathologies appear to be distinct from peripheral neuropathy.
September 30, 2026 at 12:58 PM
A Novel and Evolutionarily Conserved Metabolic Axis for Efficient Hepatic Lipid Catabolism Governed by Mfn2-Hsl-Mediated Mitochondria-Lipid Droplet Coupling https://www.biorxiv.org/content/10.64898/2026.09.28.754920v1
September 29, 2026 at 5:30 PM
A Novel and Evolutionarily Conserved Metabolic Axis for Efficient Hepatic Lipid Catabolism Governed by Mfn2-Hsl-Mediated Mitochondria-Lipid Droplet Coupling https://www.biorxiv.org/content/10.64898/2026.09.28.754920v1
September 29, 2026 at 5:30 PM
Characterization of Ataxia-linked MFN2 Variants Reveals a Lipid Droplet/Mitochondrial Axis Driving Ferroptosis https://www.medrxiv.org/content/10.64898/2026.09.19.26362166v1
September 22, 2026 at 12:40 AM
Congrats to superstar Mashiat Zaman @mashiatzaman.bsky.social, on the successful defense of his PhD thesis! Hopefully, you'll be hearing more about his work on MFN2 soon.
September 14, 2026 at 9:50 PM
New work from the lab (w/ @preronabora.bsky.social @mashiatzaman.bsky.social @mitomorph.bsky.social @nanigrotjahn.bsky.social) identifying a compound that activates OMA1-DELE1-HRI signaling to induce mitochondrial remodeling in MFN2-deficient cells. Check it out 👇
www.biorxiv.org/content/10.1...
Drug Repurposing Screen Identifies an HRI Activating Compound that Promotes Adaptive Mitochondrial Remodeling in MFN2-deficient Cells
Pathogenic variants in the mitochondrial outer membrane GTPase MFN2 cause the peripheral neuropathy Charcot-Marie-Tooth Type 2A (CMT2A). These mutations disrupt MFN2-dependent regulation of diverse as...
www.biorxiv.org
June 27, 2025 at 3:52 PM
MFN1 and MFN2 mutations cause Charcot-Marie-Tooth type 2A (CMT2A), an axonal neuropathy characterized by mitochondrial fusion defects. In the case of a GTPase domain mutant, MFN1WT showed higher efficacy than MNF2WT in rescuing th...

#MSchat #MS #Neurology #MultipleSclerosis #NeuroSky #NeuroSkyence
Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro
MFN1 and MFN2 mutations cause Charcot-Marie-Tooth type 2A (CMT2A), an axonal neuropathy characterized by mitochondrial fusion defects. In the case of a GTPase domain mutant, MFN1WT showed higher effic
gregory-ms.com
July 25, 2025 at 2:20 PM
MFN2-a multifaceted guardian against Parkinson’s pathophysiology: mitochondria, ferroptosis, inflammation and oxidative stress
Frontiers
www.frontiersin.org/journals/agi...
Frontiers | MFN2-a multifaceted guardian against Parkinson’s pathophysiology: mitochondria, ferroptosis, inflammation and oxidative stress
BackgroundParkinson’s disease (PD) is the second most prevalent neurodegenerative disease worldwide and its exact pathogenesis remains unclear. This study ai...
www.frontiersin.org
September 17, 2025 at 8:06 AM
This study shows that #miR-17 inhibition alleviates ARDS-associated #PulmonaryFibrosis in mice by reducing #LungInjury, #Collagen deposition, and #Inflammation, while promoting #Mitochondrial #Autophagy through Mfn2 regulation. #medsky

To read: doi.org/10.1007/s115...
March 11, 2026 at 3:00 AM
Low MFN2 in #HepatocellularCarcinoma activates β-catenin/EMT signaling, boosting invasion and #sorafenib resistance; MFN2 overexpression restores drug sensitivity, highlighting MFN2 as a potential therapeutic target to overcome #drugresistance.
Read: doi.org/10.1007/s115...
February 25, 2026 at 1:55 AM
This study shows that interfering with miR-17 can significantly reduce #LungFibrosis in #AcuteRespiratoryDistressSyndrome (ARDS) by regulating Mfn2, positioning miR-17 as a #therapeutic target in #ARDS-related lung fibrosis. #medsky
Read:
link.springer.com/article/10.1...
September 18, 2025 at 2:07 PM
Just in case you aren't sick of me already - here is a video of me reading my poem 'The Hare' from my forthcoming poetry collection "Grey Time". www.youtube.com/watch?v=Mfn2...
The Hare - a poem by Julia Webb
YouTube video by NineArchesPress
www.youtube.com
June 10, 2025 at 4:05 PM
I think this should be fine to say, the top band is MFN2, and treatment is every second lane getting 20 uM CCCP
February 14, 2025 at 3:46 AM